Ainos (AIMD) filed on Monday a preliminary prospectus for the resale from time to time of about 6.7 million shares by certain stockholders.
The prospectus covers 5.5 million shares issued in August as part of Ainos' patent license agreement with Taiwan Carbon Nano Technology, 500,000 shares issuable to privately held ASE Test by exercising warrants it received last May, and more than 700,000 shares issued to various directors, executives and other employees at Ainos through special stock awards vesting in recent weeks, according to the filing.
Ainos said it will not receive any proceeds from the prospective stock sales although it could receive up to $2.25 million in additional funding if ASE Test fully exercises its warrants at $4.50 per share.
Ainos shares climbed about 7% in recent trading.
Price: 0.48, Change: +0.03, Percent Change: +6.96
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。